Please Wait.....
Report
Breast Cancer Therapeutics - A Global Market Overview
Market Report I 2024-11-05 I 257 Pages I Industry Experts
Breast Cancer Therapeutics Market Trends and Outlook
Breast cancer occurs when uncontrolled growth of cells in the breast leads to the formation of a tumor that can invade nearby tissues or spread to other parts of the body. It is the most common cancer diagnosed in women, although it can also affect men, and the second most common cause of death from cancer among women worldwide. Breast cancer can be classified based on its molecular properties, such as hormone receptor-positive or HER2-positive subtypes, which affect treatment decisions. The global market for Breast Cancer Therapeutics is estimated at US$34.8 billion in 2024 and is anticipated to record a CAGR of 8.2% during the 2024-2030 analysis period and stand at a projected US$55.8 billion by 2030.
Breast cancer therapeutics comprises targeted therapy, chemotherapy, radiation, hormone therapy, and immunotherapy. Each treatment targets cancer cells in specific ways-chemotherapy eliminates rapidly dividing cells, hormone therapy disrupts hormones that support cancer growth, and targeted therapies like CDK inhibitors focus on particular proteins. Surgery, either lumpectomy or mastectomy, is commonly used to remove the tumor. Molecular biology advancements have resulted in more precise treatments, enhancing outcomes and survival rates, particularly when identified early through screenings like mammograms.
The breast cancer therapeutics market growth is driven by an increasing prevalence of breast cancer, greater awareness of early detection, and advancements in treatment technologies such as targeted therapies and immunotherapies. Focusing on personalized medicine, especially HER2-targeted therapies and immunotherapies, has improved patient outcomes. Moreover, the surge in innovative treatment options is being contributed to by supportive government initiatives and increased investment in research and development by pharmaceutical companies. These advancements are reshaping the treatment landscape, offering more precise therapies that result in better efficacy and fewer side effects and are propelling demand worldwide.
Breast Cancer Therapeutics Regional Market Analysis
North America leads the global breast cancer therapeutics market, with an estimated market share of 41.2% in 2024, driven by advanced healthcare infrastructure, high breast cancer incidence, early adoption of innovative therapies, and strong R&D efforts by major pharmaceutical companies. Rigorous regulatory frameworks and robust early detection programs also contribute to this dominance. Meanwhile, Asia-Pacific is expected to record the fastest CAGR of 10.4% during the analysis period 2024-2030, driven by rising breast cancer awareness, improved healthcare infrastructure, increasing disposable incomes, and government-led screening programs, which boost demand for advanced and personalized treatment options.
Breast Cancer Therapeutics Market Analysis by Therapy Type
The Breast Cancer Therapeutics market is primarily led by targeted therapy, projected to hold a 71.7% share in 2024. This dominance is driven by its widespread acceptance in both developed and emerging markets and the introduction of numerous new products and a wide range of available drugs. Targeted treatments, such as trastuzumab and pertuzumab, have revolutionized the management of HER2-positive breast cancer by targeting cancerous cells while sparing healthy tissue, resulting in improved survival rates. Similarly, treatments for hormone receptor-positive breast cancer, such as tamoxifen and CDK4/6 inhibitors, effectively reduce tumor growth and improve patient outcomes. Conversely, the immunotherapy sector is anticipated to record the fastest CAGR of 10.2% during the forecast period 2024-2030, with checkpoint inhibitors and specialized vaccines showing promise for triple-negative breast cancer. With the advancements in research & development, immunotherapy has become a significant component of breast cancer therapeutics due to its potential for sustained responses and enhanced survival rates.
Breast Cancer Therapeutics Market Analysis by Cancer Type
The hormone receptor segment dominates the breast cancer therapeutics market, capturing 67.3% of the market share in 2024 due to the rising prevalence of hormone receptor-positive breast cancer cases. Hormone receptors, primarily estrogen and progesterone, are essential for cell growth as they serve as signal receivers on breast cells. On the other hand, the HER2-Positive (HER2+) segment is projected to be the fastest-growing market with a CAGR of 9% during the forecast period 2024-2030. This growth is fueled by the overexpression of the HER2 protein, recent product launches, and pharmaceutical companies' strategic efforts to develop effective therapies. Targeted treatments such as trastuzumab and pertuzumab have markedly improved outcomes for patients with HER2-positive breast cancer.
Breast Cancer Therapeutics Market Analysis by Distribution Channel
The hospital pharmacies segment is the largest distribution channel market, holding an estimated share of 51.5% in 2024, primarily due to patients' reliance on these facilities for administering therapies like immunotherapy and chemotherapy. Hospital pharmacies are essential in preparing and dispensing cancer treatments, managing inventory, and ensuring compliance with strict regulations. They also play a vital role in patient education and collaboration with healthcare teams, enhancing the quality of care and improving patient outcomes. Conversely, the online pharmacies segment is projected to grow at the fastest CAGR of 9.7% during the analysis period 2024-2030, driven by the convenience of purchasing medications online. The rise of e-commerce, advancements in digital healthcare, and the impact of the COVID-19 pandemic have further accelerated the popularity of online pharmacies, which provide easy access to a wide range of breast cancer drugs and support medication delivery.
Breast Cancer Therapeutics Market Report Scope
This global report on Breast Cancer Therapeutics analyzes the market based on therapy type, cancer type, and distribution channels. In addition to providing profiles of major companies operating in this space, the latest corporate and industrial developments have been covered to offer a clear panorama of how and where the market is progressing.
Key Metrics
Historical Period: 2021-2023
Base Year: 2023
Forecast Period: 2024-2030
Units: Value market in US$
Companies Mentioned: 15+
Breast Cancer Therapeutics Market by Geographic Region
- North America (The United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, and Rest of Europe)
- Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific)
- South America (Brazil, Argentina, and Rest of South America)
- Rest of World
Breast Cancer Therapeutics Market by Therapy Type
- Targeted therapy
- Hormonal therapy
- Chemotherapy
- Immunotherapy
Breast Cancer Therapeutics Market by Cancer Type
- Hormone Receptor
- HER2-Positive (HER2+)
Breast Cancer Therapeutics Market by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
PART A: GLOBAL MARKET PERSPECTIVE
1. INTRODUCTION
- Therapy Type Outline
- Breast Cancer Therapeutics Defined
- Breast Cancer Therapeutic Therapy Types
o Targeted therapy
o Hormonal therapy
o Chemotherapy
o Immunotherapy
- Breast Cancer Therapeutic Cancer Types
o Hormone Receptor
o HER2-Positive (HER2+)
- Breast Cancer Therapeutic Distribution Channels
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
2. Key Market Trends
3. Key Global Players
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca plc
- Bristol-Myers Squibb Company
- Eisai Co., Ltd.
- Eli Lilly and Company
- F. Hoffmann-La Roche AG
- Gilead Sciences, Inc.
- GSK plc
- Johnson & Johnson Innovative Medicine
- Kyowa Kirin Co., Ltd.
- MacroGenics Inc.
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi S.A.
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceutical Industries Ltd
- Viatris Inc.
4. Key Business Trends
5. Global Market Overview
- Global Breast Cancer Therapeutics Market Overview by Therapy Type
o Breast Cancer Therapeutics Therapy Type Market Overview by Global Region
- Targeted therapy
- Hormonal therapy
- Chemotherapy
- Immunotherapy
- Global Breast Cancer Therapeutics Market Overview by Cancer Type
o Breast Cancer Therapeutics Market Overview for Cancer Type by Global Region
- Hormone Receptor
- HER2-Positive (HER2+)
- Global Breast Cancer Therapeutics Market Overview by Distribution Channel
o Breast Cancer Therapeutics Distribution Channel Market Overview by Global Region
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
PART B: REGIONAL MARKET PERSPECTIVE
- Global Breast Cancer Therapeutics Market Overview by Geographic Region
REGIONAL MARKET OVERVIEW
6. North America
- North American Breast Cancer Therapeutics Market Overview by Geographic Region
- North American Breast Cancer Therapeutics Market Overview by Therapy Type
- North American Breast Cancer Therapeutics Market Overview by Cancer Type
- North American Breast Cancer Therapeutics Market Overview by Distribution Channel
- Country-wise Analysis of North American Breast Cancer Therapeutics Market
o The United States
- United States Breast Cancer Therapeutics Market Overview by Therapy Type
- United States Breast Cancer Therapeutics Market Overview by Cancer Type
- United States Breast Cancer Therapeutics Market Overview by Distribution Channel
o Canada
- Canadian Breast Cancer Therapeutics Market Overview by Therapy Type
- Canadian Breast Cancer Therapeutics Market Overview by Cancer Type
- Canadian Breast Cancer Therapeutics Market Overview by Distribution Channel
o Mexico
- Mexican Breast Cancer Therapeutics Market Overview by Therapy Type
- Mexican Breast Cancer Therapeutics Market Overview by Cancer Type
- Mexican Breast Cancer Therapeutics Market Overview by Distribution Channel
7. Europe
- European Breast Cancer Therapeutics Market Overview by Geographic Region
- European Breast Cancer Therapeutics Market Overview by Therapy Type
- European Breast Cancer Therapeutics Market Overview by Cancer Type
- European Breast Cancer Therapeutics Market Overview by Distribution Channel
- Country-wise Analysis of European Breast Cancer Therapeutics Market
o Germany
- German Breast Cancer Therapeutics Market Overview by Therapy Type
- German Breast Cancer Therapeutics Market Overview by Cancer Type
- German Breast Cancer Therapeutics Market Overview by Distribution Channel
o France
- French Breast Cancer Therapeutics Market Overview by Therapy Type
- French Breast Cancer Therapeutics Market Overview by Cancer Type
- French Breast Cancer Therapeutics Market Overview by Distribution Channel
o The United Kingdom
- United Kingdom Breast Cancer Therapeutics Market Overview by Therapy Type
- United Kingdom Breast Cancer Therapeutics Market Overview by Cancer Type
- United Kingdom Breast Cancer Therapeutics Market Overview by Distribution Channel
o Italy
- Italian Breast Cancer Therapeutics Market Overview by Therapy Type
- Italian Breast Cancer Therapeutics Market Overview by Cancer Type
- Italian Breast Cancer Therapeutics Market Overview by Distribution Channel
o Spain
- Spanish Breast Cancer Therapeutics Market Overview by Therapy Type
- Spanish Breast Cancer Therapeutics Market Overview by Cancer Type
- Spanish Breast Cancer Therapeutics Market Overview by Distribution Channel
o Rest of Europe
- Rest of Europe Breast Cancer Therapeutics Market Overview by Therapy Type
- Rest of Europe Breast Cancer Therapeutics Market Overview by Cancer Type
- Rest of Europe Breast Cancer Therapeutics Market Overview by Distribution Channel
8. Asia-Pacific
- Asia-Pacific Breast Cancer Therapeutics Market Overview by Geographic Region
- Asia-Pacific Breast Cancer Therapeutics Market Overview by Therapy Type
- Asia-Pacific Breast Cancer Therapeutics Market Overview by Cancer Type
- Asia-Pacific Breast Cancer Therapeutics Market Overview by Distribution Channel
- Country-wise Analysis of Asia-Pacific Breast Cancer Therapeutics Market
o Japan
- Japanese Breast Cancer Therapeutics Market Overview by Therapy Type
- Japanese Breast Cancer Therapeutics Market Overview by Cancer Type
- Japanese Breast Cancer Therapeutics Market Overview by Distribution Channel
o China
- Chinese Breast Cancer Therapeutics Market Overview by Therapy Type
- Chinese Breast Cancer Therapeutics Market Overview by Cancer Type
- Chinese Breast Cancer Therapeutics Market Overview by Distribution Channel
o India
- Indian Breast Cancer Therapeutics Market Overview by Therapy Type
- Indian Breast Cancer Therapeutics Market Overview by Cancer Type
- Indian Breast Cancer Therapeutics Market Overview by Distribution Channel
o South Korea
- South Korean Breast Cancer Therapeutics Market Overview by Therapy Type
- South Korean Breast Cancer Therapeutics Market Overview by Cancer Type
- South Korean Breast Cancer Therapeutics Market Overview by Distribution Channel
o Rest of Asia-Pacific
- Rest of Asia-Pacific Breast Cancer Therapeutics Market Overview by Therapy Type
- Rest of Asia-Pacific Breast Cancer Therapeutics Market Overview by Cancer Type
- Rest of Asia-Pacific Breast Cancer Therapeutics Market Overview by Distribution Channel
9. South America
- South American Breast Cancer Therapeutics Market Overview by Geographic Region
- South American Breast Cancer Therapeutics Market Overview by Therapy Type
- South American Breast Cancer Therapeutics Market Overview by Cancer Type
- South American Breast Cancer Therapeutics Market Overview by Distribution Channel
- Country-wise Analysis of Asia-Pacific Breast Cancer Therapeutics Market
o Brazil
- Brazilian Breast Cancer Therapeutics Market Overview by Therapy Type
- Brazilian Breast Cancer Therapeutics Market Overview by Cancer Type
- Brazilian Breast Cancer Therapeutics Market Overview by Distribution Channel
o Argentina
- Argentine Breast Cancer Therapeutics Market Overview by Therapy Type
- Argentine Breast Cancer Therapeutics Market Overview by Cancer Type
- Argentine Breast Cancer Therapeutics Market Overview by Distribution Channel
o Rest of South America
- Rest of South American Breast Cancer Therapeutics Market Overview by Therapy Type
- Rest of South American Breast Cancer Therapeutics Market Overview by Cancer Type
- Rest of South American Breast Cancer Therapeutics Market Overview by Distribution Channel
10. Rest of World
- Rest of World Breast Cancer Therapeutics Market Overview by Therapy Type
- Rest of World Breast Cancer Therapeutics Market Overview by Cancer Type
- Rest of World Breast Cancer Therapeutics Market Overview by Distribution Channel
PART C: GUIDE TO THE INDUSTRY
PART D: ANNEXURE
1. RESEARCH METHODOLOGY
2. FEEDBACK
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security